Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David N Louis

Showing results (111-120 of 218) with videos related to

Pageof 22
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2011
Rapid radiographic and clinical improvement after treatment of a MET-amplified recurrent glioblastoma with a mesenchymal-epithelial transition inhibitorAndrew S Chi, Tracy T Batchelor, Eunice L Kwak, et al.
Human Gene Therapy|June 14, 2003
Potentiated gene delivery to tumors using herpes simplex virus/Epstein-Barr virus/RV tribrid amplicon vectorsJürgen A Hampl, Sara M Camp, Wojciech K Mydlarz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Age-dependent prognostic effects of genetic alterations in glioblastomaTracy T Batchelor, Rebecca A Betensky, J Matthew Esposito, et al.
Journal of Neuropathology and Experimental Neurology|February 24, 2011
A sensitive and specific diagnostic panel to distinguish diffuse astrocytoma from astrocytosis: chromosome 7 gain with mutant isocitrate dehydrogenase 1 and p53Sandra Camelo-Piragua, Michael Jansen, Aniruddha Ganguly, et al.
Neuro-Oncology|January 24, 2009
Long-term control of disseminated pleomorphic xanthoastrocytoma with anaplastic features by means of stereotactic irradiationTomoyuki Koga, Akio Morita, Keisuke Maruyama, et al.
Journal of Neuropathology and Experimental Neurology|April 10, 2002
Impact of genotype and morphology on the prognosis of glioblastomaMatthias C Schmidt, Sven Antweiler, Nina Urban, et al.
Acta Neuropathologica|May 10, 2016
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summaryDavid N Louis, Arie Perry, Guido Reifenberger, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2006
Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responsesGiulia Fulci, Laura Breymann, Davide Gianni, et al.
Journal of Neuropathology and Experimental Neurology|June 17, 2004
The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomasKeith L Ligon, John A Alberta, Alvin T Kho, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 6, 2008
Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasivenessNúria de la Iglesia, Genevieve Konopka, Kah-Leong Lim, et al.
Pageof 22

Showing results (111-120 of 218) with videos related to

Sort By:
Pageof 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2011
Rapid radiographic and clinical improvement after treatment of a MET-amplified recurrent glioblastoma with a mesenchymal-epithelial transition inhibitorAndrew S Chi, Tracy T Batchelor, Eunice L Kwak, et al.
Human Gene Therapy|June 14, 2003
Potentiated gene delivery to tumors using herpes simplex virus/Epstein-Barr virus/RV tribrid amplicon vectorsJürgen A Hampl, Sara M Camp, Wojciech K Mydlarz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Age-dependent prognostic effects of genetic alterations in glioblastomaTracy T Batchelor, Rebecca A Betensky, J Matthew Esposito, et al.
Journal of Neuropathology and Experimental Neurology|February 24, 2011
A sensitive and specific diagnostic panel to distinguish diffuse astrocytoma from astrocytosis: chromosome 7 gain with mutant isocitrate dehydrogenase 1 and p53Sandra Camelo-Piragua, Michael Jansen, Aniruddha Ganguly, et al.
Neuro-Oncology|January 24, 2009
Long-term control of disseminated pleomorphic xanthoastrocytoma with anaplastic features by means of stereotactic irradiationTomoyuki Koga, Akio Morita, Keisuke Maruyama, et al.
Journal of Neuropathology and Experimental Neurology|April 10, 2002
Impact of genotype and morphology on the prognosis of glioblastomaMatthias C Schmidt, Sven Antweiler, Nina Urban, et al.
Acta Neuropathologica|May 10, 2016
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summaryDavid N Louis, Arie Perry, Guido Reifenberger, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2006
Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responsesGiulia Fulci, Laura Breymann, Davide Gianni, et al.
Journal of Neuropathology and Experimental Neurology|June 17, 2004
The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomasKeith L Ligon, John A Alberta, Alvin T Kho, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 6, 2008
Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasivenessNúria de la Iglesia, Genevieve Konopka, Kah-Leong Lim, et al.
Pageof 22